Skip to main content
Top
Published in: Gastric Cancer 1/2015

01-01-2015 | Case Report

A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer

Authors: Seiichiro Abe, Ichiro Oda, Takeshi Nakajima, Haruhisa Suzuki, Satoru Nonaka, Shigetaka Yoshinaga, Shigeki Sekine, Hirokazu Taniguchi, Ryoji Kushima, Satoru Iwasa, Yutaka Saito, Hitoshi Katai

Published in: Gastric Cancer | Issue 1/2015

Login to get access

Abstract

Currently in Japan, differentiated-type gastric submucosal invasive cancers <500 μm with negative lymphovascular involvement are included in expanded pathological criteria for curative endoscopic treatment. This categorization is based on a retrospective examination of surgical resection cases in which patients suitable for such expanded criteria were determined to have a negligible risk of lymph node metastasis. We performed endoscopic submucosal dissection on a 66-year-old man with early gastric cancer in June 2004, and pathology revealed a well-differentiated adenocarcinoma, 16 × 8 mm in size, minute submucosal invasion depth (100 μm), and negative lymphovascular invasion or ulceration as well as tumor-free margins, so the case was diagnosed as a curative resection. In this case, however, local recurrence and distant metastasis resulted in August 2011. The patient received systemic chemotherapy but died of gastric cancer 23 months after recurrence.
Literature
1.
go back to reference Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.PubMedCrossRef Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.PubMedCrossRef
2.
go back to reference Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.PubMedCrossRef Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.PubMedCrossRef
3.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
4.
go back to reference Oda I, Saito D, Tada M, Iishi H, Tanabe S, Oyama T, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006;9:262–70.PubMedCrossRef Oda I, Saito D, Tada M, Iishi H, Tanabe S, Oyama T, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006;9:262–70.PubMedCrossRef
5.
go back to reference Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58:331–6.PubMedCrossRef Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58:331–6.PubMedCrossRef
6.
go back to reference Goto O, Fujishiro M, Kodashima S, Ono S, Omata M. Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria. Endoscopy. 2009;41:118–22.PubMedCrossRef Goto O, Fujishiro M, Kodashima S, Ono S, Omata M. Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria. Endoscopy. 2009;41:118–22.PubMedCrossRef
7.
go back to reference Ahn JY, Jung HY, Choi KD, Choi JY, Kim MY, Lee JH, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc. 2011;74:485–93.PubMedCrossRef Ahn JY, Jung HY, Choi KD, Choi JY, Kim MY, Lee JH, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc. 2011;74:485–93.PubMedCrossRef
8.
go back to reference Gotoda T, Iwasaki M, Kusano C, Seewald S, Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–71.PubMedCrossRef Gotoda T, Iwasaki M, Kusano C, Seewald S, Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–71.PubMedCrossRef
9.
go back to reference Toyonaga T, Man-i M, East JE, Nishino E, Ono W, Hirooka T, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;2013(27):1000–8.CrossRef Toyonaga T, Man-i M, East JE, Nishino E, Ono W, Hirooka T, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;2013(27):1000–8.CrossRef
10.
go back to reference Kosaka T, Endo M, Toya Y, Abiko Y, Kudara N, Inomata M et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center retrospective study. Dig Endosc 2013 Apr. doi:10.1111/den.12099. [Epub ahead of print]. Kosaka T, Endo M, Toya Y, Abiko Y, Kudara N, Inomata M et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center retrospective study. Dig Endosc 2013 Apr. doi:10.​1111/​den.​12099. [Epub ahead of print].
11.
go back to reference Tanabe S, Ishido K, Higuchi K, Sasaki T, Katada C, Azuma M et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center. Gastric Cancer 2013 Apr 11. [Epub ahead of print]. Tanabe S, Ishido K, Higuchi K, Sasaki T, Katada C, Azuma M et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center. Gastric Cancer 2013 Apr 11. [Epub ahead of print].
12.
go back to reference Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Odagaki T, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45:703–7.PubMedCrossRef Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Odagaki T, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45:703–7.PubMedCrossRef
13.
go back to reference Oya H, Gotoda T, Kinjo T, Suzuki H, Yoshinaga S, Taniguchi H, et al. A case of lymph node metastasis following a curative endoscopic submucosal dissection of an early gastric cancer. Gastric Cancer. 2012;15:221–5.PubMedCrossRef Oya H, Gotoda T, Kinjo T, Suzuki H, Yoshinaga S, Taniguchi H, et al. A case of lymph node metastasis following a curative endoscopic submucosal dissection of an early gastric cancer. Gastric Cancer. 2012;15:221–5.PubMedCrossRef
14.
go back to reference Oda I, Oyama T, Abe S, Ohnita K, Kosaka T, Hirasawa K, et al. Preliminary results of multicenter questionnaire study on long-term outcomes of curative endoscopic submucosal dissection for early gastric cancer. Dig Endosc 2013 Jul 5. doi:10.1111/den.12141. [Epub ahead of print]. Oda I, Oyama T, Abe S, Ohnita K, Kosaka T, Hirasawa K, et al. Preliminary results of multicenter questionnaire study on long-term outcomes of curative endoscopic submucosal dissection for early gastric cancer. Dig Endosc 2013 Jul 5. doi:10.​1111/​den.​12141. [Epub ahead of print].
15.
go back to reference Kurokawa Y, Hasuike N, Ono H, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. A phase II trial of endoscopic submucosal dissection for mucosal gastric cancer: Japan Clinical Oncology Group Study JCOG0607. Jpn J Clin Oncol. 2009;39:464–6.PubMedCrossRef Kurokawa Y, Hasuike N, Ono H, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. A phase II trial of endoscopic submucosal dissection for mucosal gastric cancer: Japan Clinical Oncology Group Study JCOG0607. Jpn J Clin Oncol. 2009;39:464–6.PubMedCrossRef
16.
go back to reference Oda I, Shimazu T, Ono H, Tanabe S, Iishi H, Kondo H, et al. Design of Japanese multicenter prospective cohort study of endoscopic resection for early gastric cancer using Web registry (J-WEB/EGC). Gastric Cancer. 2012;15:451–4.PubMedCrossRef Oda I, Shimazu T, Ono H, Tanabe S, Iishi H, Kondo H, et al. Design of Japanese multicenter prospective cohort study of endoscopic resection for early gastric cancer using Web registry (J-WEB/EGC). Gastric Cancer. 2012;15:451–4.PubMedCrossRef
17.
go back to reference Takizawa K, Takashima A, Kimura A, Mizusawa J, Hasuike N, Ono H, Gastrointestinal Endoscopy Study Group (GIESG) of Japan Clinical Oncology Group (JCOG), Stomach Cancer Study Group (SCSG) of Japan Clinical Oncology Group (JCOG), et al. A phase II clinical trial of endoscopic submucosal dissection for early gastric cancer of undifferentiated type: Japan Clinical Oncology Group study JCOG1009/1010. Jpn J Clin Oncol. 2013;43:87–91.PubMedCrossRef Takizawa K, Takashima A, Kimura A, Mizusawa J, Hasuike N, Ono H, Gastrointestinal Endoscopy Study Group (GIESG) of Japan Clinical Oncology Group (JCOG), Stomach Cancer Study Group (SCSG) of Japan Clinical Oncology Group (JCOG), et al. A phase II clinical trial of endoscopic submucosal dissection for early gastric cancer of undifferentiated type: Japan Clinical Oncology Group study JCOG1009/1010. Jpn J Clin Oncol. 2013;43:87–91.PubMedCrossRef
18.
go back to reference Feng XY, Chen YB, Wang W, Guan YX, Li YF, Chen S, et al. Time-varying pattern of recurrence risk for gastric cancer patients. Med Oncol. 2013;30:514.PubMedCrossRef Feng XY, Chen YB, Wang W, Guan YX, Li YF, Chen S, et al. Time-varying pattern of recurrence risk for gastric cancer patients. Med Oncol. 2013;30:514.PubMedCrossRef
19.
go back to reference Choi JY, Ha TK, Kwon SJ. Clinicopathologic characteristics of gastric cancer patients according to the timing of the recurrence after curative surgery. J Gastric Cancer. 2011;11:46–54.PubMedCentralPubMedCrossRef Choi JY, Ha TK, Kwon SJ. Clinicopathologic characteristics of gastric cancer patients according to the timing of the recurrence after curative surgery. J Gastric Cancer. 2011;11:46–54.PubMedCentralPubMedCrossRef
20.
go back to reference Sasaki A, Kitadai Y, Ito M, Sumii M, Tanaka S, Yoshihara M, et al. Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol. 2003;38:153–8.PubMedCrossRef Sasaki A, Kitadai Y, Ito M, Sumii M, Tanaka S, Yoshihara M, et al. Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol. 2003;38:153–8.PubMedCrossRef
Metadata
Title
A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer
Authors
Seiichiro Abe
Ichiro Oda
Takeshi Nakajima
Haruhisa Suzuki
Satoru Nonaka
Shigetaka Yoshinaga
Shigeki Sekine
Hirokazu Taniguchi
Ryoji Kushima
Satoru Iwasa
Yutaka Saito
Hitoshi Katai
Publication date
01-01-2015
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2015
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-014-0341-7

Other articles of this Issue 1/2015

Gastric Cancer 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine